Which stocks are trading higher in pre-market and real-time?

Sharps Technology (STSS) is trading higher in pre-market and real-time, here's why: 1. **Recent Capital Raise**: Sharps Technology recently completed a $20 million public offering, which has bolstered its financial position and provided it with the funds to support strategic initiatives. 2. **Analyst Optimism**: The company has received an "Outperform" rating from brokerage firms, with analysts setting a remarkable one-year price target of $352.00, suggesting a potential upside of 2,514,185.71% from the current price. 3. **Potential Strategic Deals**: Sharps Technology has announced a $30 million purchase order for its specialty copolymer prefillable syringes from Nephron Pharmaceuticals, which represents a significant commitment to the company's product line. Additionally, the company is negotiating a potential five-year purchase agreement with Nephron, which could further solidify its position as Nephron's exclusive pre-filled copolymer syringe manufacturer. In conclusion, Sharps Technology's stock is trading higher in pre-market and real-time due to a combination of factors including its recent capital raise, optimistic analyst ratings, and potential strategic deals. These elements are contributing to increased investor confidence and driving the stock's pre-market performance.